{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:01:30Z","timestamp":1648746090718},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00108-008-2092-1","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T15:41:25Z","timestamp":1204299685000},"page":"413-421","source":"Crossref","is-referenced-by-count":4,"title":["Chronische Nierenerkrankungen und kardiovaskul\u00e4res System"],"prefix":"10.1007","volume":"49","author":[{"given":"J.","family":"Mann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.F.","family":"Hilgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Veelken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.L.","family":"Schiffrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,1]]},"reference":[{"key":"2092_CR1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","volume":"110","author":"De","year":"2004","unstructured":"De Zeeuw D, Remuzzi G, Parving HH et al. (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110: 921\u2013927","journal-title":"Circulation"},{"key":"2092_CR2","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","volume":"15","author":"Endemann","year":"2004","unstructured":"Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15: 1983\u20131992","journal-title":"J Am Soc Nephrol"},{"key":"2092_CR3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D et al. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296\u20131305","journal-title":"N Engl J Med"},{"key":"2092_CR4","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","volume":"106","author":"Hillege","year":"2002","unstructured":"Hillege HL, Fidler V, Diercks GFH et al. (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777\u20131782","journal-title":"Circulation"},{"key":"2092_CR5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","volume":"102","author":"Hillege","year":"2000","unstructured":"Hillege HL, Girbes AR, De Kam PJ et al. (2000) Renal function, neurohormonal activation and survival in patients with chronic heart failure. Circulation 102: 203\u2013210","journal-title":"Circulation"},{"key":"2092_CR6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.HYP.0000154082.72286.2a","volume":"45","author":"Ibsen","year":"2005","unstructured":"Ibsen H, Olsen MH, Wachtell K et al. (2005) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients \u2013 Losartan intervention for endpoint reduction in hypertension study. Hypertension 45: 198\u2013202","journal-title":"Hypertension"},{"key":"2092_CR7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0272-6386(96)90357-1","volume":"27","author":"Levin","year":"1996","unstructured":"Levin A, Singer J, Thompson CR et al. (1996) Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 27: 347\u2013354","journal-title":"Am J Kidney Dis"},{"key":"2092_CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","volume":"134","author":"Mann","year":"2001","unstructured":"Mann JFE, Gerstein HC, Pogue J et al. (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134: 629\u2013636","journal-title":"Ann Intern Med"},{"key":"2092_CR9","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1111\/j.1523-1755.2004.09215.x","volume":"66","author":"Mann","year":"2004","unstructured":"Mann JFE, Yi QL, Gerstein HC (2004) Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. Kidney Int 66: S59\u2013S62","journal-title":"Kidney Int"},{"key":"2092_CR10","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/diabetes.47.11.1786","volume":"47","author":"Mattock","year":"1998","unstructured":"Mattock MB, Barnes DJ, Viberti G et al. (1998) Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes 47: 1786\u20131792","journal-title":"Diabetes"},{"key":"2092_CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2006.076711","volume":"53","author":"Meinitzer","year":"2007","unstructured":"Meinitzer A, Seelhorst U, Wellnitz B et al. (2007) Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health Study). Clin Chem 53: 273\u2013283","journal-title":"Clin Chem"},{"key":"2092_CR12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0272-6386(04)00945-X","volume":"44","author":"Pinkau","year":"2004","unstructured":"Pinkau T, Mann JFE, Ndrepepa G et al. (2004) Coronary stenting in people with mild to moderate renal insufficiency: restenosis rate and cardiovascular outcomes. Am J Kid Dis 44: 627\u2013635","journal-title":"Am J Kid Dis"},{"key":"2092_CR13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V122218","volume":"12","author":"Ruilope","year":"2001","unstructured":"Ruilope LM, Salvetti A, Jamerson K et al. (2001) Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study. J Am Soc Nephrol 12: 218\u2013225","journal-title":"J Am Soc Nephrol"},{"key":"2092_CR14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.ajkd.2004.07.022","volume":"44","author":"Russo","year":"2004","unstructured":"Russo D, Palmiero G, De Blasio AP et al. (2004) Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 44: 1024\u20131030","journal-title":"Am J Kidney Dis"},{"key":"2092_CR15","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1681\/ASN.2006010012","volume":"17","author":"Sandhu","year":"2006","unstructured":"Sandhu S, Wiebe N, Fried LF, Tonelli M (2006) Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol 17: 2006\u20132016","journal-title":"J Am Soc Nephrol"},{"key":"2092_CR16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","volume":"42","author":"Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC et al.; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 42: 1050\u20131065","journal-title":"Hypertension"},{"key":"2092_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","volume":"116","author":"Schiffrin","year":"2007","unstructured":"Schiffrin EL, Lipmann ML, Mann JFE (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116: 85\u201397","journal-title":"Circulation"},{"key":"2092_CR18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","volume":"137","author":"Shlipak","year":"2002","unstructured":"Shlipak MG, Heidenreich PA, Noguchi H et al. (2002) Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137: 555\u2013562","journal-title":"Ann Intern Med"},{"key":"2092_CR19","doi-asserted-by":"crossref","unstructured":"Shulman NB, Ford CE, Hall WD et al. (1989) Prognostic value of serum creatinine and the effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension (Suppl) 13: I80-I93","DOI":"10.1161\/01.HYP.13.5_Suppl.I80"},{"key":"2092_CR20","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"Tonelli","year":"2006","unstructured":"Tonelli M, Wiebe N, Culleton B et al. (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17: 2034\u20132047","journal-title":"J Am Soc Nephrol"},{"key":"2092_CR21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI24066","volume":"115","author":"Xu","year":"2005","unstructured":"Xu J, Li G, Wang P et al. (2005) Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 115: 1275\u20131280","journal-title":"J Clin Invest"},{"key":"2092_CR22","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","volume":"358","author":"Zoccali","year":"2001","unstructured":"Zoccali C, Bode-Boger SM, Mallamaci F et al. (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358: 2113\u20132117","journal-title":"Lancet"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2092-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-008-2092-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2092-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,5]],"date-time":"2021-09-05T01:01:28Z","timestamp":1630803688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-008-2092-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["2092"],"URL":"https:\/\/doi.org\/10.1007\/s00108-008-2092-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}